SelfAssayGrade your stack
Compound dossier

RETATRUTIDE

Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors

ACommunity BenefitWeight Management & Appetite
BAE signal

What is RETATRUTIDE?

Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors. In clinical trials, it produced unprecedented weight loss results, making it potentially the most effective obesity treatment developed.

Across SelfAssay's corpus, RETATRUTIDE appears in 1,258 first-hand reports from 1,446 contributors, with overall community sentiment that reads as positive. Most of that discussion centers on Weight Management & Appetite, Energy & Stimulation, and Mood & Well-being.

On SelfAssay, RETATRUTIDE has a A (strong) Community Benefit read and a B (moderate selected observed signal) observed AE-signal read. These are independent signals: how reliably people report the benefit they were after, and the identifiable-author share reporting selected serious or meaningful adverse events.

What people use RETATRUTIDE for

Weight Management & Appetite1,054 reportsA
Energy & Stimulation97 reportsC
Mood & Well-being84 reportsB
Cardiometabolic & Heart Health70 reportsA
Physical Performance & Recovery60 reportsB
Community × Research
Community = first-hand reports · Research = human trials (tap a verdict to read the cited studies)
community & research agree · they diverge
A
Community grade · Weight Management & Appetite
Backed by trials in patients for weight management & appetite, and the community agrees.
UseCommunityResearch
Weight Management & AppetitemainABacked · patients21
Energy & StimulationCNot studied·
Mood & Well-beingBNot studied·
Cardiometabolic & Heart HealthABacked · patients14
Physical Performance & RecoveryBNot studied·
Sleep Quality & InsomniaDNot studied·
+ 6 more uses
AE signalB4.8% of 1482 deduplicated identifiable authors reported a selected serious or meaningful adverse event (e.g. kidney stone, fainting sensation, tachycardia). The severity-weighted AE signal used for the letter was 2.2% before sample-size adjustment toward a fixed conservative 1.8% prior in either direction. 526 deleted-author comments were excluded because independent people cannot be established. A = lower observed AE signal, D = higher. Decision support, not a clinical claim.

What users report

From 1,258 first-hand reports across the community corpus.

Most-reported effects
weight loss 447appetite suppression 179reduced-food-noise 40muscle-retention 21reduced-alcohol-cravings 17increased-energy 15improved-cholesterol 14improved-insulin-resistance 12
Most-reported side effects
fatigue 43increased-heart-rate 37nausea 36anhedonia 33skin-sensitivity 28stomach-discomfort 21

What the community says about RETATRUTIDE

Weight Loss and Appetite Control1,225 reports

Many people find retatrutide to be a helpful tool for weight loss, often describing it as a way to manage their intake and silence food noise compared to other options. While some users report significant visceral fat reduction and successful body recomposition, others note that appetite suppression can vary widely, with some feeling it immediately at doses as low as 0.5mg and others requiring a gradual increase toward 6mg or higher to notice a shift. A few individuals have experienced challenges like fatigue or sleep disturbances, leading some to prefer other compounds, but many others highlight that the drug’s ability to curb cravings for sugar makes it a useful choice for long-term consistency.

Side Effect Management and Titration957 reports

Managing retatrutide side effects seems to be a highly individual process, with many users finding success by starting at very low doses like 0.5mg or 1mg and titrating up slowly to avoid intense reactions. While some people report mild nausea or fatigue that subsides as their body adapts, others struggle with more significant issues like allodynia or severe skin sensitivity, which some have mitigated with antihistamines or by simply lowering their dosage. Many find that splitting their weekly dose helps maintain steady levels and minimizes spikes in side effects, though others prefer a consistent weekly or 5-day schedule to keep things simple. Ultimately, the consensus is to listen to your body, track your trends, and be patient, as finding your personal 'sweet spot' often requires a bit of trial and error.

Stacking and Synergistic Protocols846 reports

Many users are stacking retatrutide with a wide range of compounds like TRT, growth hormone, and various peptides to amplify fat loss, muscle retention, and overall energy. Some report impressive results by combining retatrutide with tesamorelin or BPC-157 for recovery, while others experiment with complex protocols involving MOTS-c, SS-31, and GHK-Cu for cellular health and anti-aging. A few individuals noted that while stacking can be highly effective, it requires careful management of side effects like nausea or sleep disturbances, leading some to adjust their timing or switch to daily dosing for a smoother experience.

Metabolic Effects and Energy Regulation550 reports

While some find retatrutide helps reduce brain fog and increases productivity, others experience a stark contrast, reporting fatigue, lethargy, or insomnia that can persist for weeks. A few users manage these energy dips by optimizing their intake of protein, electrolytes, and mitochondrial-supporting supplements, though some outliers find the side effects, such as elevated resting heart rate or sleep disruption, significant enough to switch back to previous medications. Overall, the experience varies widely, with some feeling wired and others struggling with exhaustion, suggesting that individual metabolic responses and titration strategies play a major role in how the drug affects daily energy.

Psychological and Behavioral Shifts300 reports

Many people report that retatrutide does much more than just help with weight, acting as a powerful tool for quieting mental noise and curbing various addictive behaviors like smoking and drinking. While some users describe feeling liberated and more productive with a newfound sense of clarity, a few others have struggled with significant side effects like anhedonia, mood swings, or increased anxiety. These experiences seem to vary widely, with some finding it helps manage ADHD symptoms better than traditional stimulants, while others feel it blunts their joy or impacts their libido. Ultimately, it seems to be a deeply personal journey, as some users thrive on low doses, while others find the psychological shifts, whether positive or negative, to be the most defining part of their experience.

Themes are clustered from first-hand reports and summarized automatically. They describe what people report, not clinical fact.

RETATRUTIDE & your bloodwork

Documented to lower hba1c · PMID 37385280
Documented to lower ast · PMID 40489581
Documented to raise egfr · PMID 40630318
Documented to lower fasting glucose · PMID 40291085
Documented to lower ggt · PMID 40489581
Documented to lower ldl · PMID 40726454

Research and evidence for RETATRUTIDE

Community Benefit figures come from qualified first-hand reports for the displayed purpose; the observed AE signal uses its separate deduplicated identifiable-author denominator. The 147 studies and 32 registered clinical trials linked below are research context only: they are not reconciled to the headline purpose or outcome and do not award either community grade. Published studies also document measurable effects on lab markers including hba1c, ast, and egfr, each linked to its source on PubMed below. Displayed counts and grades are computed from their stated source and denominator, not generated; unavailable inputs are withheld rather than presented as a favorable result.

Is RETATRUTIDE safe?

RETATRUTIDE carries an observed AE-signal grade of B (moderate selected observed signal), derived from 1,482 deduplicated identifiable authors reporting selected serious or meaningful adverse events rather than from a clinical risk model. The side effects people mention most often are fatigue, increased-heart-rate, nausea, and anhedonia. This is not a complete safety profile, and RETATRUTIDE can interact with other compounds and existing conditions. Review any plan with a qualified clinician before use.

Frequently asked questions

What is RETATRUTIDE?

Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors. In clinical trials, it produced unprecedented weight loss results, making it potentially the most effective obesity treatment developed.

What is RETATRUTIDE used for?

In SelfAssay's community corpus, RETATRUTIDE is most often used for Weight Management & Appetite, Energy & Stimulation, Mood & Well-being, and Cardiometabolic & Heart Health. Each use case is graded separately, based on how consistently users report the result they were after.

What effects do people report from RETATRUTIDE?

The most frequently reported effects are weight loss, appetite suppression, reduced-food-noise, muscle-retention, and reduced-alcohol-cravings. Overall community sentiment toward RETATRUTIDE reads as positive, drawn from 1,258 first-hand reports.

What are the side effects of RETATRUTIDE?

The side effects users mention most often are fatigue, increased-heart-rate, nausea, anhedonia, and skin-sensitivity. These are self-reported and not a complete safety profile; consult a clinician before use.

Is RETATRUTIDE safe?

SelfAssay does not determine clinical safety. Its observed AE-signal grade is B (moderate selected observed signal), based on deduplicated identifiable-author reports and not your individual health context.

How effective is RETATRUTIDE?

RETATRUTIDE holds a Community Benefit grade of A (strong) on SelfAssay, with its strongest grade for Weight Management & Appetite. The grade reflects aggregated community reports; linked research is shown separately as context and results are not guaranteed.

How much research is there on RETATRUTIDE?

SelfAssay's view of RETATRUTIDE draws on 147 studies, 32 registered clinical trials, and 1,258 first-hand community reports, refreshed as new evidence is published.

Does RETATRUTIDE affect lab markers or bloodwork?

Published studies document RETATRUTIDE as changing markers including hba1c, ast, egfr, and fasting glucose. Each is linked to its PubMed source on this page.

1,258first-hand reports
1,446unique authors
147studies
32clinical trials

Grade your own stack, free

See how RETATRUTIDE reads alongside everything else you take across community Benefit, observed adverse-event signals, pair context, and linked Evidence context. Incomplete pair coverage stays provisional instead of being presented as an all-clear.

Grade my stack
More compounds
BPC-157TB-500MOTS-cSemaxSelankDSIPMelanotan 2BromantaneEpitalon

Decision support, not medical advice. Grades reflect community-reported experience and published literature, not a clinical assessment of your individual case. RETATRUTIDE is provided for informational purposes; consult a qualified clinician before use.